{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01308",
      "entity_text" : "insulin",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:12443252",
      "entity_text" : "Tauroursodeoxycholic acid",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Tauroursodeoxycholic acid (TUDCA), a chemical chaperone used to treat cholelithiasis and cholestatic liver disease, has been shown to alleviate ER stress in obese and diabetic mouse models, normalize hyperglycemia, increase insulin sensitivity, resolve the fatty liver disease and enhance insulin action in liver, muscle and adipose tissues [XREF_BIBR].",
  "reading_complete" : "2020-07-28T14:03:43Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T13:54:14Z",
  "trigger" : "enhance",
  "evidence" : [ "Tauroursodeoxycholic acid (TUDCA), a chemical chaperone used to treat cholelithiasis and cholestatic liver disease, has been shown to alleviate ER stress in obese and diabetic mouse models, normalize hyperglycemia, increase insulin sensitivity, resolve the fatty liver disease and enhance insulin" ],
  "pmc_id" : "3282906",
  "score" : 0
}